Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · IEX Real-Time Price · USD
29.46
+0.50 (1.73%)
At close: Jul 19, 2024, 4:00 PM
29.35
-0.11 (-0.37%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of $351.81 million as of July 22, 2024. Its market cap has increased by 628.39% in one year.
Market Cap
351.81M
Enterprise Value
234.44M
1-Year Change
628.39%
Ranking
Category
Stock Price
Market Cap Chart
Since March 28, 2018, Q32 Bio's market cap has decreased from $673.30M to $351.81M, a decrease of -47.75%. That is a compound annual growth rate of -9.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 351.80M | 899.43% |
Dec 29, 2023 | 35.20M | -51.38% |
Dec 30, 2022 | 72.40M | -65.19% |
Dec 31, 2021 | 208.00M | -59.30% |
Dec 31, 2020 | 511.00M | -43.94% |
Dec 31, 2019 | 911.50M | 8.72% |
Dec 31, 2018 | 838.40M | 24.52% |
Mar 28, 2018 | 673.30M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
uniQure | 375.77M |
Lexeo Therapeutics | 368.66M |
TScan Therapeutics | 365.81M |
Talkspace | 358.04M |
Vanda Pharmaceuticals | 355.59M |
Xeris Biopharma Holdings | 350.63M |
Cartesian Therapeutics | 345.49M |
AC Immune | 345.21M |